Trial Profile
RATAF -RATe Control in Atrial Fibrillation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Diltiazem (Primary) ; Metoprolol (Primary) ; Verapamil (Primary)
- Indications Atrial fibrillation
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms RATAF
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 29 Aug 2012 Status changed from active, no longer recruiting to completed.